Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Pharmacokinetic determinants of the window of selection for antimalarial drug resistance.

Antimicrobial agents and chemotherapy·2008
Same author

Comparison of characteristics of admitted emergency department patients requiring cardiopulmonary resuscitation in the ICU and non-ICU setting.

Emergency medicine journal : EMJ·2008
Same author

Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of piperaquine in plasma stable isotope labeled internal standard does not always compensate for matrix effects.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2008
Same author

Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.

Antimicrobial agents and chemotherapy·2008
Same author

Plasmodium knowlesi: the fifth human malaria parasite.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2008
Same author

Direct in vivo assessment of microcirculatory dysfunction in severe falciparum malaria.

The Journal of infectious diseases·2008
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Jul 7, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

La Melioidosis es una enfermedad que se produce por medio de la melioidosis.

N J White1

  • 1Faculty of Tropical Medicine, Mahidol University, 10400, Bangkok, Thailand. fnnjw@diamond.mahidol.ac.th <fnnjw@diamond.mahidol.ac.th>

Lancet (London, England)
|May 28, 2003
PubMed
Resumen

La melioidosis, una infección bacteriana grave, causa sepsis y mortalidad significativas en Asia y Australia. El reconocimiento temprano y el tratamiento efectivo son cruciales para mejorar los resultados de los pacientes y reducir las tasas de recaída.

Más Videos Relacionados

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Videos de Experimentos Relacionados

Last Updated: Jul 7, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Área de la Ciencia:

  • Enfermedades infecciosas Enfermedades infecciosas.
  • Microbiología Microbiología.
  • Salud Pública La salud pública.

Sus antecedentes:

  • La melioidosis, causada por Burkholderia pseudomallei, es una causa importante de sepsis en el este de Asia y el norte de Australia.
  • La bacteria es un saprofito ambiental que se encuentra en suelos húmedos, infectando principalmente a adultos con condiciones predisponentes como la diabetes.
  • La presentación de la enfermedad varía, incluida la formación de abscesos en múltiples órganos y, en algunos casos, encefalitis del tallo cerebral.

Objetivo del estudio:

  • Para resumir la epidemiología, las manifestaciones clínicas y el tratamiento de la melioidosis.
  • Para resaltar los desafíos en el manejo de esta infección grave, incluida la respuesta lenta al tratamiento y las altas tasas de recaída.

Principales métodos:

  • Revisión de la literatura existente sobre la melioidosis.
  • Análisis de datos epidemiológicos de regiones endémicas.
  • Resumen de las directrices actuales de tratamiento y resultados.

Principales resultados:

  • La melioidosis representa el 20% de las septicemias adquiridas en la comunidad en el noreste de Tailandia, con una tasa de mortalidad del 40% en los pacientes tratados.
  • La ceftazidima es el tratamiento primario para los casos graves, pero la reducción de la fiebre es lenta (mediana de 9 días).
  • La recaída ocurre en el 10% de los pacientes a pesar de la terapia prolongada con antibióticos.

Conclusiones:

  • La melioidosis sigue siendo una preocupación significativa para la salud pública en las áreas endémicas.
  • La mejora de los diagnósticos y la atención médica, junto con el aumento de los viajes, probablemente conducirá a un reconocimiento más frecuente de la melioidosis a nivel mundial.
  • Se justifica una mayor investigación para optimizar las estrategias de tratamiento y reducir las tasas de recaída.